908 Devices (MASS) Operating Income Growth (1y) (2021 - 2026)
908 Devices (MASS) Operating Income Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 16.18% |
| 10 | 908 Devices | 387.65 Mn | 286.12 Mn | 8.34 Mn | 15.51% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.51% |
| Mar 31, 2026 | -16.85% |
| Dec 31, 2025 | 118.46% |
| Sep 30, 2025 | 33.36% |
| Jun 30, 2025 | -77.55% |
| Mar 31, 2025 | -44.87% |
| Dec 31, 2024 | -72.44% |
| Sep 30, 2024 | -169.49% |
| Jun 30, 2024 | 21.94% |
| Mar 31, 2024 | 41.53% |
| Dec 31, 2023 | 6.05% |
| Sep 30, 2023 | -27.05% |
| Jun 30, 2023 | -30.71% |
| Mar 31, 2023 | -36.72% |
| Dec 31, 2022 | -193.03% |
| Sep 30, 2022 | -35.60% |
| Jun 30, 2022 | -12.26% |
| Mar 31, 2022 | -63.87% |
| Dec 31, 2021 | 9.21% |
| Sep 30, 2021 | -308.04% |